0,12% | % de acciones controlado por personas con información privilegiada |
9,34% | % de acciones controlado por instituciones |
9,35% | % de capital flotante controlado por instituciones |
92 | Número de participaciones de instituciones |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
Schroder Investment Management Group | 4.179.836 | 30 dic 2023 | 2,40% | 80.043.857 |
General Atlantic, L.P. | 4.000.000 | 30 dic 2023 | 2,30% | 76.599.998 |
Allianz Asset Management GmbH | 1.557.320 | 30 dic 2023 | 0,89% | 29.822.677 |
Bellevue Group AG | 1.131.111 | 30 dic 2023 | 0,65% | 21.660.775 |
Jane Street Group, LLC | 520.712 | 30 dic 2023 | 0,30% | 9.971.634 |
Acadian Asset Management. LLC | 488.913 | 30 dic 2023 | 0,28% | 9.362.683 |
Goldman Sachs Group Inc | 475.370 | 30 dic 2023 | 0,27% | 9.103.335 |
Aia Group Ltd | 391.278 | 30 dic 2023 | 0,22% | 7.492.973 |
Millennium Management Llc | 391.856 | 30 dic 2023 | 0,22% | 7.504.042 |
State Street Corporation | 348.770 | 30 dic 2023 | 0,20% | 6.678.945 |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
SPDR Portfolio Developed World ex-US ETF | 49.381 | 28 feb 2024 | 0,03% | 945.646 |
SSgA SPDR ETFS Europe I-SPDR MSCI Emerging Markets Small Cap UCITS ETF | 29.117 | 30 mar 2024 | 0,02% | 557.590 |
State Street Inst Inv Tr-State St All Cap Glb Equity ex-US Index Port | 21.100 | 30 dic 2023 | 0,01% | 404.064 |
Fidelity NASDAQ Composite Index Fund | 22.305 | 28 feb 2024 | 0,01% | 427.140 |
Trust For Professional Managers-PMC Diversified Equity Fund | 14.975 | 30 mar 2024 | 0,01% | 286.771 |
ETF Series Solutions-Range Cancer Therapeutics ETF | 11.212 | 28 feb 2024 | 0,01% | 214.709 |
Advisors Inner Circle Fund-Acadian Emerging Markets Port | 3.693 | 30 ene 2024 | 0,00% | 70.720 |
SEI Institutional Investment Tr-World Equity Ex-U.S. Fd | 1.061 | 28 feb 2024 | 0,00% | 20.318 |
Trust for Professional Managers-ActivePassive International Equity ETF | 8.031 | 28 feb 2024 | 0,00% | 153.793 |
ProShares Tr-Ultra Nasdaq Biotechnology Fd | 2.265 | 30 mar 2024 | 0,00% | 43.374 |